Market Overview / Executive Summary The global electrophysiology mapping and ablation devices market is on a strong growth trajectory as hospitals and cardiac electrophysiology labs scale capacity to treat rising arrhythmia prevalence—especially atrial fibrillation (AF). Valued at USD 25.07 billion in 2024, the market is projected to expand at a CAGR of 8.93% from...